Print Page  Close Window
10-Q
PARATEK PHARMACEUTICALS, INC. filed this Form 10-Q on 05/09/2018
Entire Document
 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on the 8th day of May 2018.

 

Paratek Pharmaceuticals, Inc.

 

By:

 

/s/ Michael F. Bigham

 

 

Michael F. Bigham

 

 

Chairman and Chief Executive Officer

(Principal Executive Officer)

 

By:

 

/s/ Douglas W. Pagán

 

 

Douglas W. Pagán

 

 

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 

 

 

37